New heart drug shows promise in Real-World chinese study
NCT ID NCT05728502
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study looked at how well the drug vericiguat works for Chinese adults with chronic heart failure (a condition where the heart doesn't pump blood well). Researchers compared 2400 patients taking vericiguat to similar patients receiving standard care. The goal was to see if vericiguat could reduce heart-related deaths and hospital stays over 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese Registries
Multiple Locations, Many Locations, China
Conditions
Explore the condition pages connected to this study.